Login to Your Account

Apexigen Receives $20M Series A1 Financing

By Catherine Shaffer
Staff Writer

Tuesday, August 6, 2013
Apexigen Inc., of Burlingame, Calif., reeled in a $20 million Series A1 financing to advance its cancer therapy, APX005. Ankey Ventures LLC led the financing, with participation from WSR Capital, China Development Industrial Bank, Themes Investment Partners and Sycamore Ventures.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription